Clinuvel Pharmaceuticals Ltd. (CUVL) Volatility Skew

Implied volatility skew shows how IV varies across strike prices for a given expiration. Steeper skews indicate higher demand for downside protection relative to upside speculation.

Clinuvel Pharmaceuticals Ltd. (CUVL) operates in the Healthcare sector, specifically the Medical - Pharmaceuticals industry, with a market capitalization near $310.6M, listed on NASDAQ, carrying a beta of 0.57 to the broader market. Clinuvel Pharmaceuticals Limited, a biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally. Led by Philippe Jacques Wolgen, public since 2026-07-13.

Volatility skew analysis compares implied volatility across strikes and expirations. No recent options activity for CUVL as of 2026-08-31; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how volatility skew is reported and how to read the data →